Vetigenics Aims to Solve Challenges in Canine Immunotherapy Discovery and Development
Adriann Sax has been appointed to advance Vetigenics from an academic start-up to an independent animal health biotech company. Ms Sax was hired earlier this year as the firm’s chief executive. While her undergraduate education and early career focused on animal health, Ms Sax has spent the last several decades in the human biopharma sector […]
An Interview with Adriann Sax, Biotech Executive & Entrepreneur
This week, Jason Colodne, Managing Partner at Colbeck, spoke with Adriann Sax, co-founder and CEO at Vetigenics, a prominent innovator in animal health that is one of the first companies to produce antibody-based immunotherapies for canines. She formerly served as CEO of Orsenix, a clinical stage biotech company focused on developing novel therapies to treat […]
TIAA 100th Anniversary Difference Makers: Veterinarian Helping Dogs | TIAA
More than 10,000 dogs are diagnosed with bone cancer every year in the U.S. alone. They’re often given just a year to live. In this short film by Yoruba Richen, we meet Dr. Nicola Mason, a veterinarian who’s using a new dog cancer treatment to helps dogs’ immune systems fight back, adding years to their […]